XML 57 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of stock-based compensation expense recognized
Stock-based compensation expense recognized in the consolidated statements of operations is summarized below:
 
Year Ended
December 31,
(in thousands)
2018
 
2017
 
2016
Cost of goods sold
$
1,140

 
$
1,692

 
$
359

Sales and marketing
1,244

 
640

 
339

General and administrative
4,990

 
2,964

 
1,438

Research and development
1,344

 
632

 
388

Total stock-based compensation expense
$
8,718

 
$
5,928

 
$
2,524

Schedule of option activity
A summary of option activity for 2018 is presented below:
 
 
Total
Stock
Options
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
(Years)
 
Aggregate
Intrinsic
Value
Balance at January 1, 2018
 
565,425

 
$
13.65

 
 
 
 
Options granted
 

 
$

 
 
 
 
Options exercised
 
(192,550
)
 
$
5.98

 
 
 
 
Options cancelled and expired
 
(15,800
)
 
$
20.44

 
 
 
 
Outstanding at December 31, 2018
 
357,075

 
$
17.50

 
4.4
 
535,427

Vested and expected to vest at December 31, 2018
 
357,075

 
$
17.50

 
4.4
 
535,427

Exercisable at December 31, 2018
 
353,049

 
$
17.56

 
4.4
 
522,423

Summary of restricted stock awards activity
A summary of TSR Award activity for 2018 is presented below:
 
Shares
 
Weighted-
Average Grant
Date Fair Value Per Share
Nonvested balance at January 1, 2018

 
$

Granted
206,896

 
$
22.76

Vested

 
$

Forfeited
(26,983
)
 
$
22.76

Nonvested balance at December 31, 2018
179,913

 
$
22.76

A summary of performance restricted stock award activity for 2018 is presented below:
 
Shares
 
Weighted-
Average Grant
Date Fair Value Per Share
Nonvested balance at January 1, 2018
291,172

 
$
16.70

Granted

 
$

Vested

 
$

Forfeited
(49,292
)
 
$
16.62

Nonvested balance at December 31, 2018
241,880

 
$
16.71

A summary of restricted stock awards and restricted stock units activity for 2018 is presented below:
 
Shares
 
Weighted-
Average Grant
Date Fair Value Per Share
Nonvested balance at January 1, 2018
1,765,262

 
$
5.72

Granted
647,850

 
$
15.46

Vested
(672,345
)
 
$
6.37

Forfeited
(232,228
)
 
$
11.87

Nonvested balance at December 31, 2018
1,508,539

 
$
9.51

Schedule of valuation model
The fair value of these awards are based on a Monte Carlo Simulation valuation model with the following assumptions:
            
 
 
Year Ended December 31,
 
 
2018
Expected volatility
 
84.3
%
Risk-free interest rate
 
2.4
%
Expected life (in years)
 
2.8

Expected dividend yield